These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 24825067

  • 1. JK1 (FAM134B) gene and colorectal cancer: a pilot study on the gene copy number alterations and correlations with clinicopathological parameters.
    Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK.
    Exp Mol Pathol; 2014 Aug; 97(1):31-6. PubMed ID: 24825067
    [Abstract] [Full Text] [Related]

  • 2. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
    Kasem K, Gopalan V, Salajegheh A, Lu CT, Smith RA, Lam AK.
    Exp Cell Res; 2014 Aug 01; 326(1):166-73. PubMed ID: 24973512
    [Abstract] [Full Text] [Related]

  • 3. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
    Islam F, Gopalan V, Pillai S, Lu CT, Kasem K, Lam AK.
    Genes Chromosomes Cancer; 2018 May 01; 57(5):240-251. PubMed ID: 29318692
    [Abstract] [Full Text] [Related]

  • 4. GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features.
    Gopalan V, Smith RA, Nassiri MR, Yasuda K, Salajegheh A, Kim SY, Ho YH, Weinstein S, Tang JC, Lam AK.
    Hum Pathol; 2010 Jul 01; 41(7):1009-15. PubMed ID: 20236690
    [Abstract] [Full Text] [Related]

  • 5. Altered JS-2 expression in colorectal cancers and its clinical pathological relevance.
    Lam AK, Gopalan V, Nassiri MR, Kasim K, Dissanayake J, Tang JC, Smith RA.
    Mol Oncol; 2011 Oct 01; 5(5):475-81. PubMed ID: 21802380
    [Abstract] [Full Text] [Related]

  • 6. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N, Gopalan V, Smith RA, Lam AK.
    Hum Pathol; 2013 Oct 01; 44(10):2089-96. PubMed ID: 23773481
    [Abstract] [Full Text] [Related]

  • 7. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
    Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK.
    Mol Carcinog; 2014 Feb 01; 53 Suppl 1():E36-44. PubMed ID: 24009195
    [Abstract] [Full Text] [Related]

  • 8. Novel FAM134B mutations and their clinicopathological significance in colorectal cancer.
    Islam F, Gopalan V, Wahab R, Lee KT, Haque MH, Mamoori A, Lu CT, Smith RA, Lam AK.
    Hum Genet; 2017 Mar 01; 136(3):321-337. PubMed ID: 28144752
    [Abstract] [Full Text] [Related]

  • 9. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
    Cao J, Chen XP, Li WL, Xia J, Du H, Tang WB, Wang H, Chen XW, Xiao HQ, Li YY.
    World J Gastroenterol; 2007 Feb 21; 13(7):1018-26. PubMed ID: 17373735
    [Abstract] [Full Text] [Related]

  • 10. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH, Carvalho B, Tijssen M, Beliën JA, de Wit M, Delis-van Diemen PM, Pontén F, van de Wiel MA, Fijneman RJ, Meijer GA.
    Gut; 2012 Nov 21; 61(11):1568-75. PubMed ID: 22207630
    [Abstract] [Full Text] [Related]

  • 11. Detection of APC gene deletions in colorectal malignancies using quantitative PCR in a Chinese population.
    Fang Z, Xiong Y, Li J, Liu L, Li M, Zhang W, Shi L, Wan J.
    Pathol Oncol Res; 2011 Sep 21; 17(3):657-61. PubMed ID: 21359685
    [Abstract] [Full Text] [Related]

  • 12. Molecular alterations in colorectal adenomas and intramucosal adenocarcinomas defined by high-density single-nucleotide polymorphism arrays.
    Eizuka M, Sugai T, Habano W, Uesugi N, Takahashi Y, Kawasaki K, Yamamoto E, Suzuki H, Matsumoto T.
    J Gastroenterol; 2017 Nov 21; 52(11):1158-1168. PubMed ID: 28197804
    [Abstract] [Full Text] [Related]

  • 13. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X, Wang Y, Gao N, Wang J.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb 21; 43(2):77-82. PubMed ID: 24742565
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduced p16 expression correlates with lymphatic invasion in colorectal cancers.
    Tada T, Watanabe T, Kazama S, Kanazawa T, Hata K, Komuro Y, Nagawa H.
    Hepatogastroenterology; 2003 Feb 21; 50(54):1756-60. PubMed ID: 14696398
    [Abstract] [Full Text] [Related]

  • 17. Consensus molecular subtype classification of colorectal adenomas.
    Komor MA, Bosch LJ, Bounova G, Bolijn AS, Delis-van Diemen PM, Rausch C, Hoogstrate Y, Stubbs AP, de Jong M, Jenster G, van Grieken NC, Carvalho B, Wessels LF, Jimenez CR, Fijneman RJ, Meijer GA, NGS-ProToCol Consortium:.
    J Pathol; 2018 Nov 21; 246(3):266-276. PubMed ID: 29968252
    [Abstract] [Full Text] [Related]

  • 18. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    Meng H, Li W, Boardman LA, Wang L.
    BMC Cancer; 2018 Apr 16; 18(1):433. PubMed ID: 29661177
    [Abstract] [Full Text] [Related]

  • 19. Reduced rate of copy number aberrations in mucinous colorectal carcinoma.
    Hugen N, Simmer F, Mekenkamp LJ, Koopman M, van den Broek E, de Wilt JH, Punt CJ, Ylstra B, Meijer GA, Nagtegaal ID.
    Oncotarget; 2015 Sep 22; 6(28):25715-25. PubMed ID: 26329972
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.